Expression and purification of bioactive, low-endotoxin recombinant human vitronectin

被引:3
作者
Halford, Michael M. [1 ]
He, Yi-Chao [1 ,2 ]
Stacker, Steven A. [1 ,2 ]
机构
[1] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
recombinant; human; vitronectin; integrin; endotoxin; expression; purification; endothelial; ENDOTHELIAL-CELLS; IN-VITRO; LIPOPOLYSACCHARIDE; PROTEIN; REMOVAL;
D O I
10.2144/000114181
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The secreted adhesive glycoprotein vitronectin (VTN) is a multifunctional component of plasma and the extracellular matrix. A high-yielding, inexpensive, low endotoxin source of bioactive recombinant human vitronectin (rhVTN) is highly desirable for in vitro use in diverse cell culture systems ranging from basic research settings to clinical-grade production of human cells. We describe modifications to a previously reported heparin-based affinity chromatography procedure that improve yield and achieve efficient removal of endotoxin from washed and urea-solubilized human VTN inclusion bodies following standard autoinduction of expression in Escherichia coli. This simple procedure makes accessible the low-cost expression and purification of large quantities. of bioactive rhVTN using basic equipment and facilitates its use in a spectrum of endotoxin-sensitive applications.
引用
收藏
页码:331 / 333
页数:3
相关论文
共 15 条
  • [1] Integrins in angiogenesis and lymphangiogenesis
    Avraamides, Christie J.
    Garmy-Susini, Barbara
    Varner, Judith A.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (08) : 604 - 617
  • [2] Anti-integrin monoclonal antibodies
    Byron, Adam
    Humphries, Jonathan D.
    Askari, Janet A.
    Craig, Sue E.
    Mould, A. Paul
    Humphries, Martin J.
    [J]. JOURNAL OF CELL SCIENCE, 2009, 122 (22) : 4009 - 4011
  • [3] Endotoxin-free purification for the isolation of Bovine Viral Diarrhoea Virus E2 protein from insoluble inclusion body aggregates
    Cavallaro, Antonino S.
    Mahony, Donna
    Commins, Margaret
    Mahony, Timothy J.
    Mitter, Neena
    [J]. MICROBIAL CELL FACTORIES, 2011, 10
  • [4] Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
  • [5] Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5
    Dudley, A
    McKinstry, W
    Thomas, D
    Best, J
    Jenkins, A
    [J]. BIOTECHNIQUES, 2003, 35 (04) : 724 - +
  • [6] Endotoxin: The uninvited guest
    Gorbet, MB
    Sefton, MV
    [J]. BIOMATERIALS, 2005, 26 (34) : 6811 - 6817
  • [7] Towards the biomarker-guided rational use of antiangiogenic agents in the treatment of metastatic colorectal cancer
    Halford, Michael M.
    Tebbutt, Niall C.
    Desai, Jayesh
    Achen, Marc G.
    Stacker, Steven A.
    [J]. COLORECTAL CANCER, 2012, 1 (02) : 149 - 161
  • [8] Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14
  • [9] Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells
    Li, Jian
    Bardy, Jo'an
    Yap, Lynn Y. W.
    Chen, Allen
    Nurcombe, Victor
    Cool, Simon M.
    Oh, Steve K. W.
    Birch, William R.
    [J]. BIOINTERPHASES, 2010, 5 (03) : FA132 - FA142
  • [10] Endotoxin removal and prevention for pre-clinical biologics production
    London, Anne Serdakowski
    Kerins, Brendan
    Tschantz, William R.
    Mackay, Kasey
    [J]. BIOTECHNOLOGY JOURNAL, 2012, 7 (12) : 1509 - 1516